|
Contents |
|
|
|
|
|
|
|
Classification
|
  
|
|
|
|
Hegi ME, Janzer RC, Lambiv WL, Gorlia T, Kouwenhoven MC, Hartmann C, von
Deimling A, Martinet D, Besuchet Schmutz N, Diserens AC, Hamou MF, Bady P,
Weller M, van den Bent MJ, Mason WP, Mirimanoff RO, Stupp R, Mokhtari K,
Wesseling P.
Presence
of an oligodendroglioma-like component in newly diagnosed glioblastoma
identifies a pathogenetically heterogeneous subgroup and lacks prognostic
value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
Acta Neuropathol.
2012 Jan 15. [Epub ahead of print]
|
|
|
Diagnosis
|
|
|
|
|
Arbizu J, Tejada S, Marti-Climent JM, Diez-Valle R, Prieto E, Quincoces G,
Vigil C, Idoate MA, Zubieta JL, Peñuelas I, Richter JA.
Quantitative
volumetric analysis of gliomas with sequential MRI and (11)C-methionine PET
assessment: patterns of integration in therapy planning.
Eur
J Nucl Med Mol Imaging. 2012 Jan 19. [Epub ahead of print]
|
|
|
Epidemiology
|
|
|
|
|
Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC,
Ricardi U, Slowinski J, Brandes A; RARECARE working group.
Epidemiology
of glial and non-glial brain tumours in Europe.
Eur
J Cancer. 2012 Jan 6. [Epub ahead of print]
|
|
|
Dobes M, Khurana VG, Shadbolt B, Jain S, Smith SF, Smee R, Dexter M, Cook R.
Increasing
incidence of glioblastoma multiforme and meningioma, and decreasing
incidence of Schwannoma (2000-2008): Findings of a multicenter Australian
study.
Surg Neurol Int.
2011;2:176. Epub 2011 Dec 13.
|
|
|
Sun T, Warrington NM, Rubin JB.
Why
Does Jack and not Jill Break His Crown: Sex Disparity in Brain Tumors.
Biol Sex Differ.
2012 Jan 25;3(1):3. [Epub ahead of print]
|
|
|
Etiology
& Pathogenesis
|
|
|
|
|
Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, Häcker S,
Vellanki SH, Lausen J, Debatin KM, Fulda S.
Histone
deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced
apoptosis by c-myc-mediated downregulation of cFLIP.
Oncogene. 2012 Jan 23. doi:
10.1038/onc.2011.614. [Epub ahead of print]
|
|
|
Bleeker FE, Molenaar RJ, Leenstra S.
Recent
advances in the molecular understanding of glioblastoma.
J Neurooncol.
2012 Jan 20. [Epub ahead of print]
|
|
|
Lee D, Kang SY, Suh YL, Jeong JY, Lee JI, Nam DH.
Clinicopathologic
and genomic features of gliosarcomas.
J Neurooncol.
2012 Jan 20. [Epub ahead of print]
|
|
|
Rausch T, Jones DT, Zapatka M, Stütz AM, Zichner T, Weischenfeldt J, Jäger
N, Remke M, Shih D, Northcott PA, Pfaff E, Tica J, Wang Q, Massimi L, Witt
H, Bender S, Pleier S, Cin H, Hawkins C, Beck C, von Deimling A, Hans V,
Brors B, Eils R, Scheurlen W, Blake J, Benes V, Kulozik AE, Witt O, Martin
D, Zhang C, Porat R, Merino DM, Wasserman J, Jabado N, Fontebasso A,
Bullinger L, Rücker FG, Döhner K, Döhner H, Koster J, Molenaar JJ,
Versteeg R, Kool M, Tabori U, Malkin D, Korshunov A, Taylor MD, Lichter P,
Pfister SM, Korbel JO.
Genome
Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA
Rearrangements with TP53 Mutations.
Cell. 2012 Jan 20;148(1-2):59-71.
|
|
|
Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG.
Neoplastic
cells are a rare component in human glioblastoma microvasculature.
Oncotarget. 2012 Jan 30;. [Epub ahead of print]
|
|
|
Taylor TE, Furnari FB, Cavenee WK.
Targeting
EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance.
Curr Cancer Drug
Targets. 2012 Jan 16. [Epub ahead of print]
|
|
|
Prognosis
|
|
|
|
|
Iliadis G, Kotoula V, Chatzisotiriou A, Televantou D, Eleftheraki AG,
Lambaki S, Misailidou D, Selviaridis P, Fountzilas G.
Volumetric
and MGMT parameters in glioblastoma patients: Survival analysis.
BMC Cancer. 2012 Jan 3;12:3.
|
|
|
Montano N, Cenci T, Martini M, D'Alessandris QG, Pelacchi F, Ricci-Vitiani
L, Maira G, De Maria R, Larocca LM, Pallini R.
Expression
of EGFRvIII in Glioblastoma: Prognostic Significance Revisited.
Neoplasia. 2011
Dec;13(12):1113-21.
|
|
|
Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B, Faul C.
A
clinical review of treatment outcomes in glioblastoma multiforme - the
validation in a non-trial population of the results of a randomised Phase
III clinical trial: has a more radical approach improved survival?
Br J Radiol.
2012 Jan 3. [Epub ahead of print]
|
|
|
Treatment
|
|
|
|
Laboratory
Investigations
|
|
|
|
|
Niles LP, Sathiyapalan A, Bahna S, Kang NH, Pan Y.
Valproic
acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors
CDNF and MANF in the rat brain.
Int
J Neuropsychopharmacol. 2012 Jan 16:1-8. [Epub ahead of print]
|
|
|
Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Schmainda KM.
Evaluation
of combined bevacizumab plus irinotecan therapy in brain tumors using
magnetic resonance imaging measures of relative cerebral blood volume.
Magn
Reson Med. 2011 Dec 28. doi: 10.1002/mrm.23315. [Epub ahead of print]
|
|
|
Clinical
Investigations
|
|
|
|
|
Couec ML, André N, Thebaud E, Minckes O, Rialland X, Corradini N, Aerts I,
Bérard PM, Bourdeaut F, Leblond P; on the behalf of the Comité
Pharmacologie of the SFCE.
Bevacizumab
and irinotecan in children with recurrent or refractory brain tumors:
Toxicity and efficacy trends.
Pediatr Blood Cancer.
2012 Jan 27. doi: 10.1002/pbc.24066. [Epub ahead of print]
|
|
|
Haar CP, Hebbar P, Wallace GC 4th, Das A, Vandergrift WA 3rd, Smith JA,
Giglio P, Patel SJ, Ray SK, Banik NL.
Drug
Resistance in Glioblastoma: A Mini Review.
Neurochem Res. 2012
Jan 10. [Epub ahead of print]
|
|
|
Marosi C.
Complications
of chemotherapy in neuro-oncology.
Handb
Clin Neurol. 2012;105:873-85.
|
|
|
Vauleon E, Mesbah H, Gedouin D, Lecouillard I, Louvel G, Hamlat A, Riffaud
L, Carsin B, Quillien V, Audrain O, Lesimple T.
Retrospective
analysis of 24 recurrent glioblastoma after chemoradiation and treated with
nitrosoureas or irinotecan and bevacizumab.
Bull Cancer. 2012 Jan
17. [Epub ahead of print]
|
|
|
Warrington JP, Csiszar A, Mitschelen M, Lee YW, Sonntag WE.
Whole
brain radiation-induced impairments in learning and memory are
time-sensitive and reversible by systemic hypoxia.
PLoS One. 2012;7(1):e30444. Epub
2012 Jan 18.
|
|
|
Treatment
Overviews
|
|
|
|
|
Timotheadou E.
New
agents targeting angiogenesis in glioblastoma.
Chemother Res Pract. 2011;2011:878912.
|
|
|
Patients
& Caregivers
|
|
|
|
|
International Brain Tumour Alliance
IBTA
E-News January 2012
|
|
